2 months Penn Davis Mcfarland Inc. Makes New $3.62 Million Investment in Abbott Laboratories (NYSE:ABT) MarketBeat
Penn Davis Mcfarland Inc. acquired a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquire…
Abbott Labs (ABT) · NYSE · SEC
X